Site Members can sign up for company wide alerts
Lawsuit Overview
July 02, 2024 - An investor in shares of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Bolt Biotherapeutics, Inc. in connection with certain allegedly false and misleading statements made between February 5, 2021 and May 14, 2024. Redwood City, CA based ...
You must register (for free) or login to view the entire case.